Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma – BRA-DLBCL
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 26, 2024Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:June 23, 2022Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
Condition(s):Large B-cell LymphomaLast Updated:October 10, 2023Not yet recruiting
Condition(s):Relapsed/Refractory Large B Cell LymphomaLast Updated:December 14, 2023Recruiting
Condition(s):Diffuse Large B Cell Lymphoma; Patient Reported OutcomeLast Updated:February 28, 2024Completed
Condition(s):Diffuse Large B Cell LymphomaLast Updated:December 23, 2022Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 18, 2016Completed
Condition(s):Diffuse Large B Cell LymphomaLast Updated:August 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.